{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:41:06Z","timestamp":1785901266228,"version":"3.56.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARF-19-643973"],"award-info":[{"award-number":["AARF-19-643973"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARF-19-614533"],"award-info":[{"award-number":["AARF-19-614533"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1-AG027161"],"award-info":[{"award-number":["RF1-AG027161"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1-AG027161"],"award-info":[{"award-number":["RF1-AG027161"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30-AG062715"],"award-info":[{"award-number":["P30-AG062715"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30-AG062715"],"award-info":[{"award-number":["P30-AG062715"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30-AG062715"],"award-info":[{"award-number":["P30-AG062715"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30-AG062715"],"award-info":[{"award-number":["P30-AG062715"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National lnstitute on Aging","award":["P50-AG033514"],"award-info":[{"award-number":["P50-AG033514"]}]},{"name":"National lnstitute on Aging","award":["P50-AG033514"],"award-info":[{"award-number":["P50-AG033514"]}]},{"name":"National lnstitute on Aging","award":["P50-AG033514"],"award-info":[{"award-number":["P50-AG033514"]}]},{"name":"National lnstitute on Aging","award":["P50-AG033514"],"award-info":[{"award-number":["P50-AG033514"]}]},{"DOI":"10.13039\/100016958","name":"Office of Research Infrastructure Programs, National Institutes of Health","doi-asserted-by":"publisher","award":["S10 OD025245"],"award-info":[{"award-number":["S10 OD025245"]}],"id":[{"id":"10.13039\/100016958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U54HD090256"],"award-info":[{"award-number":["U54HD090256"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Insulin resistance (IR) and type 2 diabetes have been found to increase the risk for Alzheimer\u2019s clinical syndrome in epidemiologic studies but have not been associated with tau tangles in neuropathological research and have been inconsistently associated with cerebrospinal fluid P-tau181. IR and type 2 diabetes are well-recognized vascular risk factors. Some studies suggest that cardiovascular risk may act synergistically with cortical amyloid to increase tau measured using tau PET. Utilizing data from largely nondemented middle-aged and older adult cohorts enriched for AD risk, we investigated the association of IR and diabetes to tau PET and whether amyloid moderated those relationships.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Participants were enrolled in either the Wisconsin Registry for Alzheimer\u2019s Prevention (WRAP) or Wisconsin Alzheimer\u2019s Disease Research Center (WI-ADRC) Clinical Core. Two partially overlapping samples were studied: a sample characterized using HOMA-IR (<jats:italic>n<\/jats:italic>=280 WRAP participants) and a sample characterized on diabetic status (<jats:italic>n<\/jats:italic>=285 WRAP and<jats:italic>n<\/jats:italic>=109 WI-ADRC). IR was measured using the homeostasis model assessment of insulin resistance (HOMA-IR). Tau PET employing the radioligand<jats:sup>18<\/jats:sup>F-MK-6240 was used to detect AD-specific aggregated tau. Linear regression tested the relationship of IR and diabetic status to tau PET standardized uptake value ratio (SUVR) within the entorhinal cortex and whether relationships were moderated by amyloid assessed by amyloid PET distribution volume ratio (DVR) and amyloid PET positivity status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Neither HOMA-IR nor diabetic status was significantly associated with tau PET SUVR. The relationship between IR and tau PET SUVR was not moderated by amyloid PET DVR or positivity status. The association between diabetic status and tau PET SUVR was not significantly moderated by amyloid PET DVR but was significantly moderated by amyloid PET positivity status. Among the amyloid PET-positive participants, the estimated marginal tau PET SUVR mean was higher in the diabetic (<jats:italic>n<\/jats:italic>=6) relative to the nondiabetic group (<jats:italic>n<\/jats:italic>=88).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Findings indicate that IR may not be related to tau in generally healthy middle-aged and older adults who are in the early stages of the AD clinicopathologic continuum but suggest the need for additional research to investigate whether a synergistic relationship between type 2 diabetes and amyloid is associated with increased tau levels.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13195-023-01180-2","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T09:03:10Z","timestamp":1679043790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults"],"prefix":"10.1186","volume":"15","author":[{"given":"Gilda E.","family":"Ennis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobey J.","family":"Betthauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Langhough","family":"Koscik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel A.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley T.","family":"Christian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Asthana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterling C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara B.","family":"Bendlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"1180_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1055\/s-2001-18576","volume":"109","author":"HE Lebovitz","year":"2001","unstructured":"Lebovitz HE. Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes. 2001;109:135\u201348.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1180_CR2","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/0140-6736(92)92814-V","volume":"340","author":"BC Martin","year":"1992","unstructured":"Martin BC, Warram JH, Krolewski AS, Soeldner JS, Kahn CR, Martin BC, et al. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 1992;340:925\u20139.","journal-title":"Lancet"},{"key":"1180_CR3","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/bmj.315.7115.1045","volume":"315","author":"J Kuusisto","year":"1997","unstructured":"Kuusisto J, Koivisto K, Mykkanen L, Helkala EL, Vanhanen M, Hanninen T, et al. Association between features of the insulin resistance syndrome and Alzheimer\u2019s disease independently of apolipoprotein e4 phenotype: cross sectional population based study. BMJ. 1997;315:1045\u20139. Available from: https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.315.7115.1045.","journal-title":"BMJ"},{"key":"1180_CR4","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181ffe4f6","volume":"75","author":"EMC Schrijvers","year":"2010","unstructured":"Schrijvers EMC, Witteman JCM, Sijbrands EJG, Hofman A, Koudstaal PJ, Breteler MMB. Insulin metabolism and the risk of Alzheimer disease: the Rotterdam study. Neurology. 2010;75:1982\u20137. Available from: https:\/\/www.neurology.org\/lookup\/doi\/10.1212\/WNL.0b013e3181ffe4f6.","journal-title":"Neurology"},{"key":"1180_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.tips.2017.03.011","volume":"38","author":"ME Orr","year":"2017","unstructured":"Orr ME, Sullivan AC, Frost B. A brief overview of tauopathy: causes, consequences, and therapeutic strategies. Trends Pharmacol Sci. 2017;38:637\u201348. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614717300792.","journal-title":"Trends Pharmacol Sci"},{"key":"1180_CR6","doi-asserted-by":"publisher","first-page":"19146","DOI":"10.1074\/jbc.M115.636852","volume":"290","author":"B Kim","year":"2015","unstructured":"Kim B, Figueroa-Romero C, Pacut C, Backus C, Feldman EL. Insulin resistance prevents AMPK-induced Tau dephosphorylation through Akt-mediated increase in AMPKSer-485 phosphorylation. J Biol Chem. 2015;290:19146\u201357. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820422860.","journal-title":"J Biol Chem"},{"key":"1180_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3233\/JAD-131238","volume":"39","author":"J Mehla","year":"2014","unstructured":"Mehla J, Chauhan BC, Chauhan NB. experimental induction of type 2 diabetes in aging-accelerated mice triggered alzheimer-like pathology and memory deficits. j alzheimer\u2019s dis. 2014;39:145\u201362. Available from: https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/JAD-131238.","journal-title":"j alzheimer\u2019s dis"},{"key":"1180_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00401-014-1328-5","volume":"128","author":"M Yarchoan","year":"2014","unstructured":"Yarchoan M, Toledo JB, Lee EB, Arvanitakis Z, Kazi H, Han LY, et al. Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer\u2019s disease and tauopathies. Acta Neuropathol. 2014;128:679\u201389. Available from: http:\/\/link.springer.com\/10.1007\/s00401-014-1328-5.","journal-title":"Acta Neuropathol"},{"key":"1180_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.brainresbull.2016.08.018","volume":"126","author":"T Arendt","year":"2016","unstructured":"Arendt T, Stieler JT, Holzer M. Tau and tauopathies. Brain Res Bull. 2016;126:238\u201392. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923016302325.","journal-title":"Brain Res Bull"},{"key":"1180_CR10","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/j.1460-2075.1992.tb05204.x","volume":"11","author":"J Biernat","year":"1992","unstructured":"Biernat J, Mandelkow EM, Schr\u00f6ter C, Lichtenberg-Kraag B, Steiner B, Berling B, et al. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J. 1992;11:1593\u20137. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/j.1460-2075.1992.tb05204.x.","journal-title":"EMBO J"},{"key":"1180_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1042\/bj3010871","volume":"301","author":"M Goedert","year":"1994","unstructured":"Goedert M, Jakes R, Crowther RA, Cohen P, Vanmechelen E, Vandermeeren M, et al. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer\u2019s disease: identification of phosphorylation sites in tau protein. Biochemical Journal. 1994;301:871\u20137. Available from: https:\/\/portlandpress.com\/biochemj\/article\/301\/3\/871\/31228\/Epitope-mapping-of-monoclonal-antibodies-to-the.","journal-title":"Biochemical Journal"},{"key":"1180_CR12","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1073\/pnas.88.6.2288","volume":"88","author":"RA Crowther","year":"1991","unstructured":"Crowther RA. Straight and paired helical filaments in Alzheimer disease have a common structural unit. Proc Natl Acad Sci. 1991;88:2288\u201392. Available from: http:\/\/www.pnas.org\/cgi\/doi\/10.1073\/pnas.88.6.2288.","journal-title":"Proc Natl Acad Sci"},{"key":"1180_CR13","doi-asserted-by":"publisher","first-page":"9766","DOI":"10.1038\/s41598-017-09577-4","volume":"7","author":"SM Laws","year":"2017","unstructured":"Laws SM, Gaskin S, Woodfield A, Srikanth V, Bruce D, Fraser PE, et al. Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults. Sci Rep. 2017;7:9766. Available from: http:\/\/www.nature.com\/articles\/s41598-017-09577-4.","journal-title":"Sci Rep"},{"key":"1180_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3233\/JAD-150072","volume":"46","author":"EJ Starks","year":"2015","unstructured":"Starks EJ, Patrick O\u2019Grady J, Hoscheidt SM, Racine AM, Carlsson CM, Zetterberg H, et al. Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOE \u025b4 Carriers. J Alzheimer\u2019s Dis. 2015;46:525\u201333. Available from: https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/JAD-150072.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1180_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1001\/archpsyc.61.1.95","volume":"61","author":"H Hampel","year":"2004","unstructured":"Hampel H, Buerger K, Zinkowski R, Teipel SJ, Goernitz A, Andreasen N, et al. Measurement of Phosphorylated Tau Epitopes in the Differential Diagnosis of Alzheimer Disease. Arch Gen Psychiatry. 2004;61:95\u2013102. Available from: http:\/\/archpsyc.jamanetwork.com\/article.aspx?doi=10.1001\/archpsyc.61.1.95.","journal-title":"Arch Gen Psychiatry"},{"key":"1180_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13195-017-0258-6","volume":"9","author":"S Westwood","year":"2017","unstructured":"Westwood S, Liu B, Baird AL, Anand S, Nevado-Holgado AJ, Newby D, et al. The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer\u2019s pathology. Alzheimers Res Ther. 2017;9:31. Available from: http:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-017-0258-6.","journal-title":"Alzheimers Res Ther"},{"key":"1180_CR17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.neulet.2012.04.022","volume":"516","author":"K Becker","year":"2012","unstructured":"Becker K, Freude S, Zemva J, St\u00f6hr O, Krone W, Schubert M. Chronic peripheral hyperinsulinemia has no substantial influence on tau phosphorylation in vivo. Neurosci Lett. 2012;516:306\u201310. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394012005307.","journal-title":"Neurosci Lett"},{"key":"1180_CR18","first-page":"4047","volume":"86","author":"SE Kahn","year":"2001","unstructured":"Kahn SE. The Importance of-Cell Failure in the Development and Progression of Type 2 Diabetes. J Clin Endocrinol Metab. 2001;86:4047\u201358. Available from: https:\/\/academic.oup.com\/jcem\/article\/86\/9\/4047\/2848331.","journal-title":"J Clin Endocrinol Metab"},{"key":"1180_CR19","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1212\/WNL.0000000000001982","volume":"85","author":"C Moran","year":"2015","unstructured":"Moran C, Beare R, Phan TG, Bruce DG, Callisaya ML, Srikanth V. Type 2 diabetes mellitus and biomarkers of neurodegeneration. Neurology. 2015;85:1123\u201330.","journal-title":"Neurology"},{"key":"1180_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-180914","volume":"68","author":"ON Groeneveld","year":"2019","unstructured":"Groeneveld ON, Moneti C, Heinen R, de Bresser J, Kuijf HJ, Exalto LG, et al. The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus. J Alzheimer\u2019s Dis. 2019;68:311\u201322.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1180_CR21","doi-asserted-by":"publisher","first-page":"eaaz238","DOI":"10.1126\/sciadv.aaz2387","volume":"6","author":"N Mattsson-Carlgren","year":"2020","unstructured":"Mattsson-Carlgren N, Andersson E, Janelidze S, Ossenkoppele R, Insel P, Strandberg O, et al. A\u03b2 deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer\u2019s disease. Sci Adv. 2020;6:eaaz238.","journal-title":"Sci Adv"},{"key":"1180_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00401-021-02400-5","volume":"143","author":"SA Kaeser","year":"2022","unstructured":"Kaeser SA, H\u00e4sler LM, Lambert M, Bergmann C, Bottelbergs A, Theunis C, et al. CSF p-tau increase in response to A\u03b2-type and Danish-type cerebral amyloidosis and in the absence of neurofibrillary tangles. Acta Neuropathol. 2022;143:287\u201390. Available from: https:\/\/link.springer.com\/10.1007\/s00401-021-02400-5.","journal-title":"Acta Neuropathol"},{"key":"1180_CR23","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41380-020-0721-9","volume":"26","author":"H Zetterberg","year":"2021","unstructured":"Zetterberg H, Bendlin BB. Biomarkers for Alzheimer\u2019s disease\u2014preparing for a new era of disease-modifying therapies. Mol Psychiatry. 2021;26:296\u2013308. Available from: http:\/\/www.nature.com\/articles\/s41380-020-0721-9.","journal-title":"Mol Psychiatry"},{"key":"1180_CR24","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.neuron.2018.02.015","volume":"97","author":"C Sato","year":"2018","unstructured":"Sato C, Barth\u00e9lemy NR, Mawuenyega KG, Patterson BW, Gordon BA, Jockel-Balsarotti J, et al. Tau kinetics in neurons and the human central nervous system. Neuron. 2018;97:1284\u20131298.e7. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896627318301363.","journal-title":"Neuron"},{"key":"1180_CR25","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1212\/WNL.0b013e3181eee25f","volume":"75","author":"T Matsuzaki","year":"2010","unstructured":"Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y, et al. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology. 2010;75:764\u201370. Available from: https:\/\/www.neurology.org\/lookup\/doi\/10.1212\/WNL.0b013e3181eee25f.","journal-title":"Neurology"},{"key":"1180_CR26","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1001\/jamaneurol.2013.284","volume":"70","author":"M Thambisetty","year":"2013","unstructured":"Thambisetty M, Metter EJ, Yang A, Dolan H, Marano C, Zonderman AB, et al. Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the baltimore longitudinal study of aging. JAMA Neurol. 2013;70:1167. Available from: http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2013.284.","journal-title":"JAMA Neurol"},{"key":"1180_CR27","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1212\/WNL.0b013e3181f4d7f8","volume":"75","author":"S Ahtiluoto","year":"2010","unstructured":"Ahtiluoto S, Polvikoski T, Peltonen M, Solomon A, Tuomilehto J, Winblad B, et al. Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology. 2010;75:1195\u2013202. Available from: https:\/\/www.neurology.org\/lookup\/doi\/10.1212\/WNL.0b013e3181f4d7f8.","journal-title":"Neurology"},{"key":"1180_CR28","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1212\/01.wnl.0000247053.45483.4e","volume":"67","author":"Z Arvanitakis","year":"2006","unstructured":"Arvanitakis Z, Schneider JA, Wilson RS, Li Y, Arnold SE, Wang Z, et al. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology. 2006;67:1960\u20135. Available from: https:\/\/www.neurology.org\/lookup\/doi\/10.1212\/01.wnl.0000247053.45483.4e.","journal-title":"Neurology"},{"key":"1180_CR29","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/gerona\/60.4.471","volume":"60","author":"MS Beeri","year":"2005","unstructured":"Beeri MS, Silverman JM, Davis KL, Marin D, Grossman HZ, Schmeidler J, et al. Type 2 Diabetes is negatively associated with Alzheimer\u2019s disease neuropathology. J Gerontol A Biol Sci Med Sci. 2005;60:471\u20135. Available from: https:\/\/academic.oup.com\/biomedgerontology\/article-lookup\/doi\/10.1093\/gerona\/60.4.471.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1180_CR30","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1136\/jnnp-2021-328158","volume":"93","author":"G Hadley","year":"2022","unstructured":"Hadley G, Zhang J, Harris-Skillman E, Alexopoulou Z, DeLuca GC, Pendlebury ST. Cognitive decline and diabetes: a systematic review of the neuropathological correlates accounting for cognition at death. J Neurol Neurosurg Psychiatry. 2022;93:246\u201353.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1180_CR31","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","volume":"113","author":"JA Kim","year":"2006","unstructured":"Kim JA, Montagnani M, Kwang KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;113:1888\u2013904.","journal-title":"Circulation"},{"key":"1180_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11906-009-0010-0","volume":"11","author":"IH Schulman","year":"2009","unstructured":"Schulman IH, Zhou MS. Vascular insulin resistance: a potential link between cardiovascular and metabolic diseases. Curr Hypertens Rep. 2009;11:48\u201355.","journal-title":"Curr Hypertens Rep"},{"key":"1180_CR33","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","volume":"241","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, McGee DL. Diabetes and cardiovascular disease. JAMA. 1979;241:2035\u20138. Available from: http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.1979.03290450033020.","journal-title":"JAMA"},{"key":"1180_CR34","doi-asserted-by":"crossref","unstructured":"Gast KB, Tjeerdema N, Stijnen T, Smit JWA, Dekkers OM. Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS One. 2012:7(12):e52036. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0052036.","DOI":"10.1371\/journal.pone.0052036"},{"key":"1180_CR35","doi-asserted-by":"publisher","first-page":"8573","DOI":"10.1523\/JNEUROSCI.1230-20.2020","volume":"40","author":"D Albrecht","year":"2020","unstructured":"Albrecht D, Lisette Isenberg A, Stradford J, Monreal T, Sagare A, Pachicano M, et al. Associations between vascular function and Tau PET are associated with global cognition and amyloid. Journal of Neuroscience. 2020;40:8573\u201386.","journal-title":"Journal of Neuroscience"},{"key":"1180_CR36","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ana.25399","volume":"85","author":"JS Rabin","year":"2019","unstructured":"Rabin JS, Yang HS, Schultz AP, Hanseeuw BJ, Hedden T, Viswanathan A, et al. Vascular Risk and \u03b2-Amyloid Are Synergistically Associated with Cortical Tau. Ann Neurol. 2019;85:272\u20139.","journal-title":"Ann Neurol"},{"key":"1180_CR37","doi-asserted-by":"publisher","first-page":"100068","DOI":"10.1016\/j.ynirp.2021.100068","volume":"1","author":"M Bilgel","year":"2021","unstructured":"Bilgel M, Bannerjee A, Shafer A, An Y, Resnick SM. Vascular risk is not associated with PET measures of Alzheimer\u2019s disease neuropathology among cognitively normal older adults. Neuroimage. 2021;1:100068.","journal-title":"Neuroimage"},{"key":"1180_CR38","first-page":"130","volume":"10","author":"SC Johnson","year":"2018","unstructured":"Johnson SC, Koscik RL, Jonaitis EM, Clark LR, Mueller KD, Berman SE, et al. The Wisconsin Registry for Alzheimer\u2019s prevention: a review of findings and current directions. Alzheimer\u2019s Dementia. 2018;10:130\u201342. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1016\/j.dadm.2017.11.007.","journal-title":"Alzheimer\u2019s Dementia"},{"key":"1180_CR39","doi-asserted-by":"crossref","unstructured":"Langhough Koscik R, Hermann BP, Allison S, Clark LR, Jonaitis EM, Mueller KD, et al. Validity evidence for the research category, \u201cCognitively unimpaired \u2013 declining,\u201d as a risk marker for mild cognitive impairment and Alzheimer\u2019s disease. Front Aging Neurosci. 2021:13. Article 688478. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.688478\/full.","DOI":"10.3389\/fnagi.2021.688478"},{"key":"1180_CR40","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dementia. 2011;7:270\u20139. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1016\/j.jalz.2011.03.008.","journal-title":"Alzheimer\u2019s Dementia"},{"key":"1180_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dementia. 2011;7:263\u20139. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1016\/j.jalz.2011.03.005.","journal-title":"Alzheimer\u2019s Dementia"},{"key":"1180_CR42","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487\u201395. Available from: https:\/\/diabetesjournals.org\/care\/article\/27\/6\/1487\/22836\/Use-and-Abuse-of-HOMA-Modeling.","journal-title":"Diabetes Care"},{"key":"1180_CR43","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.atherosclerosis.2006.12.018","volume":"196","author":"AE Sumner","year":"2008","unstructured":"Sumner AE, Cowie CC. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis. 2008;196:696\u2013703.","journal-title":"Atherosclerosis"},{"key":"1180_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2337\/diacare.23.2.171","volume":"23","author":"H Yeni-Komshian","year":"2000","unstructured":"Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care. 2000;23:171\u20135. Available from: https:\/\/diabetesjournals.org\/care\/article\/23\/2\/171\/19620\/Relationship-between-several-surrogate-estimates.","journal-title":"Diabetes Care"},{"key":"1180_CR45","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc10-S011","volume":"33","author":"American Diabetes Association","year":"2010","unstructured":"American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care. 2010;33:S11\u201361.","journal-title":"Diabetes Care"},{"key":"1180_CR46","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2967\/jnumed.118.209650","volume":"60","author":"TJ Betthauser","year":"2019","unstructured":"Betthauser TJ, Cody KA, Zammit MD, Murali D, Converse AK, Barnhart TE, et al. In vivo characterization and quantification of neurofibrillary tau PET radioligand 18F-MK-6240 in humans from Alzheimer disease dementia to young controls. J Nuclear Med. 2019;60:93\u20139. Available from: http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.118.209650.","journal-title":"J Nuclear Med"},{"key":"1180_CR47","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.neurobiolaging.2013.09.028","volume":"35","author":"SC Johnson","year":"2014","unstructured":"Johnson SC, Christian BT, Okonkwo OC, Oh JM, Harding S, Xu G, et al. Amyloid burden and neural function in people at risk for Alzheimer\u2019s Disease. Neurobiol Aging. 2014;35:576\u201384. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458013004302.","journal-title":"Neurobiol Aging"},{"key":"1180_CR48","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1016\/j.neurobiolaging.2015.05.004","volume":"36","author":"KE Sprecher","year":"2015","unstructured":"Sprecher KE, Bendlin BB, Racine AM, Okonkwo OC, Christian BT, Koscik RL, et al. Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adults. Neurobiol Aging. 2015;36:2568\u201376. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458015002511.","journal-title":"Neurobiol Aging"},{"key":"1180_CR49","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3233\/JAD-160528","volume":"54","author":"AM Racine","year":"2016","unstructured":"Racine AM, Clark LR, Berman SE, Koscik RL, Mueller KD, Norton D, et al. Associations between performance on an abbreviated CogState battery, other measures of cognitive function, and biomarkers in people at risk for Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2016;54:1395\u2013408. Available from: https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/JAD-160528.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1180_CR50","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112:389\u2013404.","journal-title":"Acta Neuropathol"},{"key":"1180_CR51","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/brain\/awz378","volume":"143","author":"TJ Betthauser","year":"2020","unstructured":"Betthauser TJ, Koscik RL, Jonaitis EM, Allison SL, Cody KA, Erickson CM, et al. Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age. Brain. 2020;143:320\u201335. Available from: https:\/\/academic.oup.com\/brain\/article\/143\/1\/320\/5689568.","journal-title":"Brain"},{"key":"1180_CR52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.25395","volume":"85","author":"RA Sperling","year":"2019","unstructured":"Sperling RA, Mormino EC, Schultz AP, Betensky RA, Papp K v, Amariglio RE, et al. The impact of amyloid-beta and tau on prospective cognitive decline in older individuals. Ann Neurol. 2019;85:181\u201393.","journal-title":"Ann Neurol"},{"key":"1180_CR53","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","volume":"13","author":"CR Jack","year":"2017","unstructured":"Jack CR, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, et al. Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease. Alzheimer\u2019s Dementia. 2017;13:205\u201316.","journal-title":"Alzheimer\u2019s Dementia"},{"key":"1180_CR54","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3758\/BF03192961","volume":"39","author":"AF Hayes","year":"2007","unstructured":"Hayes AF, Cai LI. Using heteroskedasticity-consistent standard error estimators in OLS regression: An introduction and software implementation. Behav Res Methods. 2007;39:709\u201322.","journal-title":"Behav Res Methods"},{"key":"1180_CR55","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/path.2912","volume":"225","author":"Y Liu","year":"2011","unstructured":"Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. Deficient brain insulin signalling pathway in Alzheimer\u2019s disease and diabetes. J Pathol. 2011;225:54\u201362. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/path.2912.","journal-title":"J Pathol"},{"key":"1180_CR56","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","volume":"31","author":"AM Moloney","year":"2010","unstructured":"Moloney AM, Griffin RJ, Timmons S, O\u2019Connor R, Ravid R, O\u2019Neill C. Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer\u2019s disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging. 2010;31:224\u201343.","journal-title":"Neurobiol Aging"},{"key":"1180_CR57","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, et al. Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Investig. 2012;122:1316\u201338. Available from: http:\/\/www.jci.org\/articles\/view\/59903.","journal-title":"J Clin Investig"},{"key":"1180_CR58","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.nbd.2014.03.011","volume":"67","author":"SE Arnold","year":"2014","unstructured":"Arnold SE, Lucki I, Brookshire BR, Carlson GC, Browne CA, Kazi H, et al. High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice. Neurobiol Dis. 2014;67:79\u201387.","journal-title":"Neurobiol Dis"},{"key":"1180_CR59","doi-asserted-by":"publisher","first-page":"e0128274","DOI":"10.1371\/journal.pone.0128274","volume":"10","author":"Z Liu","year":"2015","unstructured":"Liu Z, Patil IY, Jiang T, Sancheti H, Walsh JP, Stiles BL, et al. High-Fat diet induces hepatic insulin resistance and impairment of synaptic plasticity. PLoS One. 2015;10:e0128274. Available from: https:\/\/dx.plos.org\/10.1371\/journal.pone.0128274.","journal-title":"PLoS One"},{"key":"1180_CR60","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.nbd.2018.02.001","volume":"113","author":"IH Salas","year":"2018","unstructured":"Salas IH, Weerasekera A, Ahmed T, Callaerts-Vegh Z, Himmelreich U, D\u2019Hooge R, et al. High fat diet treatment impairs hippocampal long-term potentiation without alterations of the core neuropathological features of Alzheimer disease. Neurobiol Dis. 2018;113:82\u201396. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996118300330.","journal-title":"Neurobiol Dis"},{"key":"1180_CR61","doi-asserted-by":"publisher","first-page":"11704","DOI":"10.1523\/JNEUROSCI.2119-16.2016","volume":"36","author":"M Stanley","year":"2016","unstructured":"Stanley M, Macauley SL, Caesar EE, Koscal LJ, Moritz W, Robinson GO, et al. The effects of peripheral and central high insulin on brain insulin signaling and amyloid-\u03b2 in young and old APP\/PS1 mice. J Neurosci. 2016;36:11704\u201315. Available from: https:\/\/www.jneurosci.org\/lookup\/doi\/10.1523\/JNEUROSCI.2119-16.2016.","journal-title":"J Neurosci"},{"key":"1180_CR62","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","volume":"104","author":"C Hooper","year":"2008","unstructured":"Hooper C, Killick R, Lovestone S. The GSK3 hypothesis of Alzheimer\u2019s disease. J Neurochem. 2008;104:1433\u20139. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-4159.2007.05194.x.","journal-title":"J Neurochem"},{"key":"1180_CR63","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1093\/brain\/awx256","volume":"140","author":"P Rodriguez-Rodriguez","year":"2017","unstructured":"Rodriguez-Rodriguez P, Sandebring-Matton A, Merino-Serrais P, Parrado-Fernandez C, Rabano A, Winblad B, et al. Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons. Brain. 2017;140:3269\u201385. Available from: https:\/\/academic.oup.com\/brain\/article\/140\/12\/3269\/4523883.","journal-title":"Brain"},{"key":"1180_CR64","doi-asserted-by":"publisher","first-page":"100944","DOI":"10.1016\/j.arr.2019.100944","volume":"55","author":"M Xue","year":"2019","unstructured":"Xue M, Xu W, Ou YN, Cao XP, Tan MS, Tan L, et al. Diabetes mellitus and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 144 prospective studies. Ageing Res Rev. 2019;55:100944. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163719300157.","journal-title":"Ageing Res Rev"},{"key":"1180_CR65","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2337\/dc15-1588","volume":"39","author":"S Chatterjee","year":"2016","unstructured":"Chatterjee S, Peters SAE, Woodward M, Arango SM, Batty GD, Beckett N, et al. Type 2 diabetes as a risk factor for dementia in women compared with men: A pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes Care. 2016;39:300\u20137.","journal-title":"Diabetes Care"},{"key":"1180_CR66","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","volume":"51","author":"R Peila","year":"2002","unstructured":"Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies. Diabetes. 2002;51:1256\u201362. Available from: https:\/\/diabetesjournals.org\/diabetes\/article\/51\/4\/1256\/34635\/Type-2-Diabetes-APOE-Gene-and-the-Risk-for.","journal-title":"Diabetes"},{"key":"1180_CR67","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1212\/01.WNL.0000129989.28404.9B","volume":"63","author":"R Peila","year":"2004","unstructured":"Peila R, Rodriguez BL, White LR, Launer LJ. Fasting insulin and incident dementia in an elderly population of Japanese-American men. Neurology. 2004;63:228\u201333. Available from: https:\/\/www.neurology.org\/lookup\/doi\/10.1212\/01.WNL.0000129989.28404.9B.","journal-title":"Neurology"},{"key":"1180_CR68","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","volume":"71","author":"TG Beach","year":"2012","unstructured":"Beach TG, Monsell SE, Phillips LE, Kukull W. Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. J Neuropathol Exp Neurol. 2012;71:266\u201373. Available from: https:\/\/academic.oup.com\/jnen\/article\/71\/4\/266\/2917384.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1180_CR69","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","volume":"14","author":"GJ Biessels","year":"2018","unstructured":"Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14:591\u2013604.","journal-title":"Nat Rev Endocrinol"},{"key":"1180_CR70","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jalz.2018.09.008","volume":"15","author":"LR Clark","year":"2019","unstructured":"Clark LR, Koscik RL, Allison SL, Berman SE, Norton D, Carlsson CM, et al. Hypertension and obesity moderate the relationship between \u03b2-amyloid and cognitive decline in midlife. Alzheimer\u2019s Dementia. 2019;15:418\u201328.","journal-title":"Alzheimer\u2019s Dementia"},{"key":"1180_CR71","doi-asserted-by":"publisher","first-page":"e3093","DOI":"10.1212\/WNL.0000000000010946","volume":"95","author":"C Pettigrew","year":"2020","unstructured":"Pettigrew C, Soldan A, Wang J, Wang MC, Arthur K, Moghekar A, et al. Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline. Neurology. 2020;95:e3093\u2013103.","journal-title":"Neurology"},{"key":"1180_CR72","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/brain\/awu393","volume":"138","author":"P Vemuri","year":"2015","unstructured":"Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Preboske GM, Kantarci K, et al. Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly. Brain. 2015;138:761\u201371.","journal-title":"Brain"},{"key":"1180_CR73","doi-asserted-by":"crossref","unstructured":"K\u00f6be T, Gonneaud J, Pichet Binette A, Meyer PF, McSweeney M, Rosa-Neto P, et al. Association of Vascular Risk Factors with \u03b2-Amyloid Peptide and Tau Burdens in Cognitively Unimpaired Individuals and Its Interaction with Vascular Medication Use. JAMA Netw Open. 2020;3(2):e1920780. Available from: https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2760441.","DOI":"10.1001\/jamanetworkopen.2019.20780"},{"key":"1180_CR74","doi-asserted-by":"publisher","first-page":"972","DOI":"10.2337\/dc18-1399","volume":"42","author":"EC McIntosh","year":"2019","unstructured":"McIntosh EC, Nation DA. Importance of treatment status in links between type 2 diabetes and Alzheimer\u2019s disease. Diabetes Care. 2019;42:972\u20139. Available from: https:\/\/diabetesjournals.org\/care\/article\/42\/5\/972\/40492\/Importance-of-Treatment-Status-in-Links-Between.","journal-title":"Diabetes Care"},{"key":"1180_CR75","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40478-019-0686-6","volume":"7","author":"C Aguero","year":"2019","unstructured":"Aguero C, Dhaynaut M, Normandin MD, Amaral AC, Guehl NJ, Neelamegam R, et al. Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue. Acta Neuropathol Commun. 2019;7:37. Available from: https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-019-0686-6.","journal-title":"Acta Neuropathol Commun"},{"key":"1180_CR76","unstructured":"CDC. United States Diabetes Surveillance System. https:\/\/gis.cdc.gov\/grasp\/diabetes\/DiabetesAtlas.html2019;"},{"key":"1180_CR77","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1212\/01.wnl.0000324925.95210.6d","volume":"71","author":"MS Beeri","year":"2008","unstructured":"Beeri MS, Schmeidler J, Silverman JM, Gandy S, Wysocki M, Hannigan CM, et al. Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology. Neurology. 2008;71:750\u20137. Available from: https:\/\/www.neurology.org\/lookup\/doi\/10.1212\/01.wnl.0000324925.95210.6d.","journal-title":"Neurology"},{"key":"1180_CR78","doi-asserted-by":"publisher","first-page":"e001218","DOI":"10.1136\/bmjdrc-2020-001218","volume":"8","author":"A Bullock","year":"2020","unstructured":"Bullock A, Sheff K, Hora I, Burrows NR, Benoit SR, Saydah SH, et al. Prevalence of diagnosed diabetes in American Indian and Alaska Native adults, 2006\u20132017. BMJ Open Diabetes Res Care. 2020;8:e001218. Available from: https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2020-001218.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1180_CR79","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1001\/jama.2019.19365","volume":"322","author":"YJ Cheng","year":"2019","unstructured":"Cheng YJ, Kanaya AM, Araneta MRG, Saydah SH, Kahn HS, Gregg EW, et al. Prevalence of diabetes by race and ethnicity in the United States, 2011-2016. JAMA. 2019;322:2389. Available from: https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2757817.","journal-title":"JAMA"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-023-01180-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-023-01180-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-023-01180-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T03:22:01Z","timestamp":1702092121000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-023-01180-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1180"],"URL":"https:\/\/doi.org\/10.1186\/s13195-023-01180-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"assertion":[{"value":"14 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent prior to study participation. Study procedures were approved by the University of Wisconsin \u2013 Madison Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}